T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.82B | |
| 2 | +$1.38B | |
| 3 | +$1.16B | |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| 1 | +$4.73B | |
| 2 | +$3.54B | |
| 3 | +$1.75B | |
| 4 |
Amphenol
APH
|
+$1.65B |
| 5 |
KLA
KLAC
|
+$1.5B |
Sector Composition
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Oric Pharmaceuticals
ORIC
$789M
| $68.3M | 0.01% |
5,387,783
+2,092,661
|
|
||
702
T. Rowe Price Dividend Growth ETF
TDVG
$1.34B
| $68.1M | 0.01% |
1,525,001
|
|
||
703
Astera Labs
ALAB
$60.7B
| $67.8M | 0.01% |
618,499
-545,915
|
|
||
704
MP Materials
MP
$10B
| $67.3M | 0.01% |
1,393,457
-349,218
|
|
||
705
HealthEquity
HQY
$7.41B
| $67.1M | 0.01% |
803,427
-514,292
|
|
||
706
Celldex Therapeutics
CLDX
$2.35B
| $66.2M | 0.01% |
2,086,332
+46,627
|
|
||
707
Occidental Petroleum
OXY
$56.5B
| $65.8M | 0.01% |
1,011,915
-29,292
|
|
||
708
Arrowhead Research
ARWR
$10.5B
| $65.4M | 0.01% |
1,043,732
+204,914
|
|
||
709
American Healthcare REIT
AHR
$9.7B
| $65.4M | 0.01% |
1,386,305
+384,367
|
|
||
710
Beam Therapeutics
BEAM
$3.01B
| $64.7M | 0.01% |
2,713,230
-17,052
|
|
||
711
Douglas Emmett
DEI
$2.06B
| $64.4M | 0.01% |
6,836,853
-36,910
|
|
||
712
Ford
F
$57.8B
| $64.4M | 0.01% |
5,577,749
-155,939
|
|
||
713
ESCO Technologies
ESE
$8.15B
| $64.3M | 0.01% |
228,578
+76,278
|
|
||
714
Wave Life Sciences
WVE
$1.11B
| $63.1M | 0.01% |
8,704,550
+1,297,178
|
|
||
715
Stoke Therapeutics
STOK
$1.81B
| $63M | 0.01% |
1,934,171
+1,561,837
|
|
||
716
Viridian Therapeutics
VRDN
$1.77B
| $62.7M | 0.01% |
3,206,035
-233,379
|
|
||
717
Immunome
IMNM
$2.07B
| $62.5M | 0.01% |
2,858,863
-521,377
|
|
||
718
On Holding
ONON
$12.9B
| $62.5M | 0.01% |
1,835,806
-902,886
|
|
||
719
Replimune Group
REPL
$730M
| $62.1M | 0.01% |
8,121,433
-140,863
|
|
||
720
Delta Air Lines
DAL
$52.5B
| $62M | 0.01% |
932,460
-17,684
|
|
||
721
Essential Utilities
WTRG
$10.6B
| $61.7M | 0.01% |
1,532,975
+1,296,496
|
|
||
722
Iron Mountain
IRM
$37.1B
| $61.4M | 0.01% |
601,581
-5,278
|
|
||
723
Universal Technical Institute
UTI
$2.23B
| $61.4M | 0.01% |
1,700,286
+100,752
|
|
||
724
Fastly Inc
FSLY
$2.93B
| $61.3M | 0.01% |
2,108,776
+1,947,756
|
|
||
725
CoStar Group
CSGP
$13.4B
| $61.2M | 0.01% |
1,517,795
+318,963
|
|